ECMO is high risk for the patient, especially venoarterial (VA) ECMO which is probably
not what is being described in this article. Venovenous (VV) ECMO doesn't dump blood into the arterial tree, so your risk of stroke or other arterial thrombotic complications is much lower. You still risk infection and venous clotting (and therefore the risks of iatrogenic anticoagulation), but I think most of us would accept those risks.
From a systems standpoint, the use of mechanical support usually makes sense in the context of being a bridge to somewhere that is not in-hospital, even in the event of non-recovery. At least where I practice, we want to be able to offer a durable device, or transplantation, if you don't recover. If you live in a place where the health system would not offer transplantation (e.g., because of some risk factor like advanced age), then offering ECMO makes less sense because it is not a bridge to anywhere, particularly for VA ECMO.
For VV ECMO, I think there has long been a recognition that people can do OK for an extended period of time (in contrast to VA ECMO, where the risks are higher and there are also destination therapies like ventricular assist devices). And if you're waiting for a lung transplant vs recovery, you may be waiting for quite awhile. To this end, there are special catheters for VV ECMO that facilitate mobility so you can retain some degree of strength and mobility while on ECMO (e.g., https://www.getinge.com/int/product-catalog/avalon-elite-bi-... ).
I'm closer to VA ECMO than to VV ECMO (but do neither); still, your comments ring more true for me about VV ECMO (which again I think is the subject of this article), whereas I think that patient risk + superior bridging/destination strategies really do dominate the VA ECMO discussion.